Expanded footprint provides access to healthcare for 86% of Florida's
Medicare eligible population
WELLINGTON, Fla., Nov. 10 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP), a Wellington, Florida based healthcare organization, announced today Quantum subsidiary Renaissance Health Systems of Florida, Inc. has expanded into three additional Florida Counties bringing the Company total to 29 counties. These counties geographically represent 86% of Florida's Medicare population.
Noel J. Guillama, President and CEO of The Quantum Group stated, "We are pleased by our continued expansion. Our presence in these three new counties was strategically planned to offer access to our provider system in the counties with the greatest number of Medicare eligible residents to our payor partners."
Barbara Roqueta, Senior Vice President of Operations for Renaissance Health Systems, commented, "The quality of our team responsible for developing these new counties, or as we call them community health systems (CHS), is first rate. The experience and dedication of this team is key to our success as they continue to build the quality and accessibility of our CHS."
The Company has projected expansion plans to the remaining counties in Florida and expects to announce further developments during Fiscal Year 2009 which began November 1, 2008.
About The Quantum Group, Inc.
The Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.
Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $600 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation's largest and fastest growing industry.
We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives. Through approximately 2,000 healthcare providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to the Florida healthcare industry.
Certain statements contained in this news release, which are not based
on historical facts, are forward-looking statements as the term is defined
in the Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K
filings (and amendments thereto) that may cause actual results to
materially differ from projections. Forward-looking statements can be
identified by the use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates" and other words
of similar meaning. These statements are subject to risks and uncertainties
that cannot be predicted or quantified and, consequently, actual results
may differ materially from those expressed or implied by these
forward-looking statements. Such risk factors include, without limitation,
the ability of the Company to properly execute its business model, to raise
substantial and immediate additional capital to implement its business
model, to attract and retain executive, management and operational
personnel, to continue growing its patient base, to negotiate favorable
current debt and future capital raises, to negotiate favorable agreements
with a diversified provider base and to continue to supply the services
needed by its HMO clients as well as physician clients. The Company does
not undertake any obligation to publicly update any forward-looking
statements. There can be no assurance that the provisional patents
discussed in this press release will be granted by the US Patent and
Trademark Office, or, if they are granted, they will not be challenged by
third parties, or if not that we will be able to effectively use or
commercialize such patents and/or we may not have the resources to deploy
such technology. As a result, investors should not place undue reliance on
these forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT:
PR Financial Marketing
Jim Blackman: 713-256-0369
The Quantum Group, Inc.
Danielle Amodio: 561.798.9800
|SOURCE The Quantum Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved